You just read:

PDL BioPharma Closes Equity Investment Transaction in Noden Pharma for the Acquisition of Tekturna® (aliskiren) and Tekturna HCT® (aliskiren and hydrochlorothiazide)

News provided by

PDL BioPharma, Inc.

06 Jul, 2016, 07:00 ET